Table 1. Baseline characteristics of the train cohort comparing survived vs non-survived patients
| Â | Survivor (n=506) | Non-survivor (n=246) | P |
|---|---|---|---|
Age, yr (median [IQR]) | 58.19 [46.64, 68.06] | 64.25 [55.00, 76.92] | <0.001 |
BMI (median [IQR]) | 28.53 [24.10, 35.34] | 27.64 [23.73, 33.53] | 0.187 |
Gender(male) | 284 (56.1%) | 138 (56.1%) | >0.999 |
Comorbidity, n (%) | |||
Asthma | 28 (5.5) | 10 (4.1) | 0.493 |
CHF | 126 (24.9) | 71 (28.9) | 0.284 |
AFIB | 93 (18.4) | 55 (22.4) | 0.234 |
Renal diseases | 37 (7.3) | 29 (11.8) | 0.058 |
Liver diseases | 17 (3.4) | 20 (8.1) | 0.008 |
COPD | 65 (12.8) | 30 (12.2) | 0.893 |
CAD | 41 (8.1) | 19 (7.7) | 0.971 |
Diabetes | 70 (13.8) | 32 (13.0) | 0.844 |
Hypertension | 120 (23.7) | 49 (19.9) | 0.281 |
Stroke | 27 (5.3) | 16 (6.5) | 0.631 |
Malignancy | 53 (10.5) | 39 (15.9) | 0.046 |
Number of comorbidities, n (%) | Â | Â | 0.297 |
0 | 179 (35.4) | 66 (26.8) | Â |
1 | 139 (27.5) | 76 (30.9) | Â |
2 | 93 (18.4) | 49 (19.9) | Â |
3 | 50 (9.9) | 35 (14.2) | Â |
4 | 28 (5.5) | 13 (5.3) | Â |
5 | 13 (2.6) | 4 (1.6) | Â |
6 | 3 (0.6) | 2 (0.8) | Â |
7 | 1 (0.2) | 1 (0.4) | Â |
Vasopressor usage | 182 (36.0) | 111 (45.1) | 0.020 |
ARDS severity, n (%) * | Â | Â | 0.003 |
Mild | 60 (11.9) | 28 (11.4) | Â |
Moderate | 226 (44.7) | 80 (32.5) | Â |
Severe | 220 (43.5) | 138 (56.1) | Â |
Subgroup of ARDS, n (%) | Â | Â | 0.643 |
Direct (pulmonary) ARDS | 325 (64.2) | 153 (62.2) | Â |
Indirect (extrapulmonary) ARDS | 181 (35.6) | 93 (37.8) | Â |
Severity score | |||
SAPS II (median [IQR]) | 41.00 [32.00, 50.00] | 49.00 [39.00, 60.00] | <0.001 |
SOFA (median [IQR]) | 7.00 [4.00, 9.00] | 8.00 [5.00, 11.00] | <0.001 |
OASIS (median [IQR]) | 36.00 [31.00, 42.00] | 40.00 [34.00, 45.00] | <0.001 |
APACHE IV (median [IQR]) | 72.00 [53.00, 91.00] | 91.50 [70.75, 114.75] | <0.001 |
APPS (median [IQR]) | 6.00 [5.00, 7.00] | 6.00 [5.00, 7.00] | <0.001 |